Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
incomplete course of vaccine administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received in 2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: incomplete course of vaccine administration). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 18-JUL-2025 The reporter had a question that if patient had first dose of Shingrix last in 2023, and willing to re comply this year, will 2 doses be approved this year? Or was it even safe to give another series (2-6 months apart). What was your recommendation for those that had one dose and then never followed up to complete the series? Till the time of reporting the patient did not receive the second dose which led to incomplete course of vaccination.